Dominic Marasco's most recent trade in Mannkind Corp was a trade of 72,500 Performance Restricted Stock Unit done . Disclosure was reported to the exchange on May 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mannkind Corp | Dominic Marasco | Pres, Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 72,500 | 72,500 | - | - | Performance Restricted Stock Unit | |
Mannkind Corp | Dominic Marasco | Pres, Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 59,500 | 311,500 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
Mannkind Corp | Dominic Marasco | Pres, Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 4.56 per share. | 14 May 2025 | 21,929 | 333,429 (0%) | 0% | 4.6 | 99,996 | Common Stock, $0.01 Par Value |
Mannkind Corp | Dominic Marasco | Pres, Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 252,000 | 252,000 (0%) | 0% | 0 | Common Stock, $0.01 Par Value |